Inclusion and exclusion criteria
diabetic retinopathy, corneal opacity, hyperopia, uveitis, cataract, senile cataract, traumatic cataract, diabetic, glaucoma, cataracts, type 2 diabetes mellitus
DIABETIC RETINOPATHY, PSEUDOEXFOLIATION SYNDROME, OCULAR HYPERTENSION, INTRAOPERATIVE COMPLICATIONS, EYE DISEASE, HYPEROPIA, UVEITIS, HYPERMATURE CATARACT, CATARACT, IRIS NEOVASCULARIZATION, COLLAGEN VASCULAR DISEASE, HIGH MYOPIA, DIABETIC MACULAR EDEMA, GLAUCOMA, CATARACTS, TYPE 2 DIABETES MELLITUS
A total of 95 diabetic patients, aged 50 to 85, with moderate cataracts (N2 + and N3+), 47 undergoing PHACO and 48 undergoing FLACS, were selected randomly for the study. All patients were diagnosed with type 2 diabetes mellitus under clinical treatment (glycated hemoglobin < 7.0 being the criterion used) who presented senile cataract and low visual acuity, which required surgical intervention and were willing to participate in the study.Exclusion criteria were the same in both groups: moderate to severe diabetic retinopathy, diabetic macular edema, traumatic cataract, mature and hypermature cataract, LOCS III nuclear cataract graduation above 4, pseudoexfoliation syndrome, significant corneal opacity, glaucoma, ocular hypertension, uveitis, vitreoretinal pathologies, previous intraocular surgery, intraoperative complications during cataract surgery, collagen vascular disease, any active eye disease, high myopia, high hyperopia (axial length < 15 mm), age of < 50 years, preoperative cell count of < 1,000 per square millimeter or preoperative anterior chamber depth of < 2.5 mm, iris neovascularization, or other abnormalities that could significantly impair endothelial cells regardless of surgery.